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Aim. The investigation of trophoblast markers expression in the mesenchymal stromal cells of placental tissue
before and after their isolation and cultivation. Methods. Placental multipotent mesenchymal stromal cells
(MMSC) were obtained by culturing the adhesive fraction of cells enzymatically isolated from the placental
tissue. The placental derived cells were immunophenotyped by flow cytometry and immunocytoche- mistry.
Results. It was shown that the placental MMSC express the trophoblast markers: human chorionic
gonadotropin, pan-cytokeratin, epidermal growth factor receptor HER2. MMSC-like populations of CD90
+
CD73
+
CD45
–
CD34
–
CD14
–
-cells and CD90
–
CD73
+
CD45
–
CD34
–
CD14
–
-cells are presented in the placental tis-
sue. Conclusions. The placental MMSC simultaneously express mesenchymal and trophoblast markers.
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Introduction. Human placenta contains multipotent
mesenchymal stromal cells (MMSC) [1]. It was shown
that the placenta derived MMSC had low immunoge-
nicity, high proliferative potential and capacity to diffe-
rentiate towards the adipogenic, chondrogenic, osteo-
genic, endothelial, neurogenic and cardiomyogenic li-
neages [2–4]. The placenta derived MMSC could be
represented by both fetal and maternal cells. We have
only few data about the features of immunophenotype
of different populations of the placental MMSC; immu-
nophenotype and ontogeny of the fetal placental MMSC
are almost completely unknown.
In some papers authors described similarity of the
placenta-derived MMSCwith pericytes [5, 6] but on the
other hand the placental MMSC expressed a range of tro-
phoblast markers. Thus we consider that the hypothesis
about perivascular origin of the placenta-derived MMSC
[6] is not enough proved.
Furthermore a lot of papers were focused on study-
ing MMSC derived from the placental tissue on an ear-
ly stage of human development (the first and second
trimesters of gestation). Together with a variety of cell
isolation methods there is also complicated analysis of
ontogeny of the placental MMSC [4, 6, 7].
Materials andmethods. Isolation and culture of pla-
cental MMSCs. Placentas (n = 7; clinically normal preg-
nancies or caesarean section) were collected after obtai-
ning written informed consent from the 23–36-year old
donors at 39–41 weak of gestation at the Kyiv city ma-
ternity hospital N 3.
The isolation and culturing of placental cells were
performed as described previously [8]. Placental tissue
was digested in DMEMwith 0.1% collagenase I («Ser-
va», Germany) and 0.6 unit/ml dispase I («Gibco»,
Germany). Harvested cells were washed and seeded
into DMEM («Sigma», USA) with 15% FBS («Gibco»),
2 mM L-glutamin, 5 mM HEPES («Biomedicals»,
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USA), 100 unit/ml penicillin, 50 µg /ml streptomycin.
Cells were cultured in the cell culture flask with adhe-
sive surface in density (80–200) 10
3 cells/cm2 at 37 °C
in humidified 5 % CO2 atmosphere. Culture medium
was changed twice a week. After MMSC reaching 80–
90% of confluence, the cells were detached with 0.05 %
trypsin with 0.02 % EDTA («Biochrom», Germany),
washed, counted and passaged at inoculation density of
(4–5) 10
3/cm2.
Flow cytometry. The freshly isolated MMSC were
washed with cold Cell Wash buffer («Becton Dickin-
son», USA), and incubated for 30 min at 4 oC with fluo-
rochrome-conjugated monoclonal antibodies at appro-
priate dilution («Becton Dickinson») 0.5 µg per 106
cells: anti-CD34 APC, anti-CD90 FITC, anti-CD45
APC-Cy7, anti-CD73 PE, anti-CD14 Pacific Blue. Un-
bounded primary antibodies were washed away with
Cell Wash buffer. The samples were analyzed using
BD FACSAria («Becton Dickinson») with software
BD FACSDiva 6.1. Each sample was analyzed for two
parameters of scattering (FSC/SSC) and five parame-
ters of fluorescence, using unstained, single stained and
fluorescence minus one (FMO) controls.
Immunocytochemistry. Immunocytochemistry was
performed as described earlier [8]. MMSC were grown
in 4-well culture dish with surface area 1.9 cm2 (Nun-
clonTM Surface). MMSC were fixed and permeabili-
zed in acetone/ methanol solution (w/w 1:1) at –20 oC
for 40 min. The endogen peroxidase activity was inhi-
bited by incubation with 0.3 % H2O2 for 5 min. Un-
specific binding of antibodies was blocked with 0.1 M
PBS with 0.5 % BSA. Detection of cytokeratins AE1/
AE3, epidermal growth factor receptor type 2 (HER2),
cytokeratin 7 (CK7), chorionic gonadotropin (CG) and
vimentin (Vim) was performed with the next primary
antibodies: mouse anti-cytokeratin AE1/AE3 («Dako»,
Denmark), rabbit anti-HER2 («Dako»), rabbit anti-cy-
tokeratin 7 («Novus Biological», USA), mouse anti-cy-
tokeratin 7 («Dako»), rabbit anti-hCG («Dako»), mou-
se anti-vimentin («Dako»).
Visualization of specific binding was also perfor-
med using Mouse/Rabbit Poly Vue HRP/DAB Detec-
tion System («DBS», USA).
Double staining for CK7 and vimentin as well as
CK7 and CD90 was performed as described earlier [9].
Secondary antibodies were donkey anti rabbit-Alexa 555
(«Invitrogen», Germany) and goat anti mouse-Alexa
488 («Invitrogen»).
Statistical analysis. Data are discribed as mean va-
lue ± s. e. m (standard error) or confidential interval.
The statistical differences between groups were asses-
sed by Mann-Whitney U-test. The results were consi-
dered statistically significant at P value  0.05.
Results and discussion. The colonies of MMSC
cells emerged on 8–12 days of culturing and reached a
confluence on the 16th day. In our previous publication
we have shown that the placental MMSC were of fetal
origin, had CD90+CD73+CD105+CD34–CD45–CD133–
CD14-immunophenotype and might differentiate in
adipocytes, osteocytes and chondrocytes [8].
Immucytochemical analysis showed that the placen-
tal MMSC were positive for the trophoblast markers:
cytokeratins AE1/AE3 (Fig. 1, A),HER2 (Fig. 1, B) and
CG (Fig. 1, C) during six passages. The placental MM
SC expressed the trophoblast marker CG and marker of
mesenchymal cells Vim simultaneously (Fig. 1, C).
The CK7 positive cells also expressed CG (Fig. 1, E)
that proves their extravillous trophoblast ontogeny
(EVT). Notably, the CK7+-cells expressed the stem
cells marker CD90 (Fig. 1, F).
The population of double positive cells for Vim and
CK7 (Fig. 1, D) significantly decreased from 37.6 %
(26.6–49.4%,) at the first passage to 13.4% (2.5–31.1%)
at the third passage (n = 6; p < 0.05).
HER2 was exclusively expressed on non-mesen-
chymal cells such as the syncytiotrophoblast and extra-
villous trophoblast (EVT) in the placental tissue but it was
also detected on the bonemarrow derivedMMSC [10].
Furthermore, the expression of cytokeratin AE1/
AE3 and CG by the placental MMSC during six passa-
ges may suggest their relationship with progenitors of
trophoblast. CG was also detected in placental stromal
cells of fetal origin in vitro [11, 12].
FACS analysis of some placental MMSC lines
showed bi-modal pattern of the expression of CD90
and correspondingly the presence of both CD90+ and
CD90– populations of cells (Fig. 2).
We showed that placental tissue in situ contain both
population of MMSC-like cells (Fig. 3) with immu-
nophenotype CD90+CD73+CD45–CD34–CD14– (0,22 ±
± 0,14 %, n = 4) and CD90–CD73+CD45–CD34–CD14–
(3,61 ± 2,45 %, n = 4). Placental stromal mesenchymal
cells characterized downregulation of CD105 [11] and
variable level of CD90 expression [12].
The expression of CD90, CD105, CD73 and the ab-
sence of CD34, CD45, CD14 on the placental stromal
cell in vitro together with the capacity to differentiate
into three mesedermal lineages indicate their relation to
MMSC but the expression of cytokeratins AE1/AE3,
CK7, HER2, CG may suggest their trophoblast origin.
The population of Vim+CG+CK7–MMSCmay be consi-
dered as mesenchymal as well as trophoblast because
some trophoblast cell lines do not express CK7 whe-
reas CG and cytokeratin AE1/AE3 [13] are expressed.
The Vim+CG+CK7+ population of MMSC has EVT-li-
ke immunophenotype and therefore we conclude about
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Fig. 2. Histograms of placental MMSC antigen profile: blue – level of
expression of CD90, CD73, CD105, CD34, CD14, CD45; (BD FACS
Diva 6.1.2 software)
Fig. 3. Two-dimensional dot-plot histo-
grams of surface markers expression CD
90, CD73, CD105, CD34, CD14, CD45
on freshly isolated cells by fermentation
of placental tissue: A – population of cells
with immunophenotype of CD90
–
CD
73
+
CD45
–
CD34
–
CD14
–
; B – population
of cells with immunophenotype of CD
90
+
CD73
+
CD45
–
CD34
–
CD14
–
; (BD FACS
Diva 6.1.2 software)
A B
A
C D
E F
Fig. 1. Immunocytochemical staining
of stromal cells culture of placenta:
detection of cytokeratin AE1/AE3
(A) and HER2 (B); immunoperoxi-
dase cytochemical analysis; brown –
positive cells, light microscopy, 100;
C – detection of CG (yellow stai-
ning) and Vim (green staining); D –
detection of Vim (green staining)
and CK7 (yellow); E – detection of
CG (yellow) and CK7 (green stai-
ning); F – detection of CK7 (red)
and CD90 (green); fluorescence mic-
roscopy
their relation to some type of EVT progenitors. Thus,
differences between mesenchymal stromal and tropho-
blast placental cells in vitro remains insufficiently clear.
Conclusions. It has been shown that the placental
MMSC express the trophoblast markers such as CG,
CK7, cytokeratin AE1/AE3, HER2. The placental cells
in situ have MMSC-like populations with both im-
munophenotypes CD90+CD73+CD45–CD34–CD14– and
CD90–CD73+CD45–CD34–CD14–.
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Ìåòà. Äîñë³äèòè åêñïðåñ³þ ìàðêåð³â òðîôîáëàñòà â ìóëüòèïî-
òåíòíèõ ñòðîìàëüíèõ êë³òèíàõ ó òêàíèí³ ïëàöåíòè òà çà óìîâ
¿õíüîãî êóëüòèâóâàííÿ.Ìåòîäè. Ìóëüòèïîòåíòí³ ìåçåíõ³ìàëüí³
ñòðîìàëüí³ êë³òèíè (ÌÌÑÊ) îòðèìóâàëè êóëüòèâóâàííÿì àäãå-
çèâíî¿ ôðàêö³¿ ñóñïåíç³¿ êë³òèí òêàíèíè ïëàöåíòè, ³ìóíîôåíîòè-
ïóâàííÿ êë³òèí ïðîâîäèëè çà äîïîìîãîþ ïðîòî÷íî¿ öèòîôëóîðî-
ìåòð³¿ òà ³ìóíîöèòîõ³ì³¿. Ðåçóëüòàòè. Ïîêàçàíî, ùî ÌÌÑÊ ïëà-
öåíòè åêñïðåñóþòü ìàðêåðè òðîôîáëàñòà: õîð³îí³÷íèé ãîíàäî-
òðîï³í, öèòîêåðàòèíè ÀÅ1/ÀÅ3, ðåöåïòîð åï³äåðìàëüíîãî ôàê-
òîðà ðîñòó HER2. Ó òêàíèí³ ïëàöåíòè ïðèñóòí³ ïîä³áí³ çà ³ìóíî-
ôåíîòèïîì äî ÌÌÑÊ ïîïóëÿö³¿ CD90
+
CD73
+
CD45
–
CD34
–
CD14
–
-
êë³òèí ³ CD90
–
CD73
+
CD45
–
CD34
–
CD14
–
-êë³òèí. Âèñíîâêè. Ïëà-
öåíòàðí³ ÌÌÑÊ îäíî÷àñíî åêñïðåñóþòü ìåçåíõ³ìàëüí³ òà òðî-
ôîáëàñòí³ ìàðêåðè.
Êëþ÷îâ³ ñëîâà: ïëàöåíòà, õîð³îí, ìóëüòèïîòåíòí³ ìåçåíõ³-
ìàëüí³ ñòðîìàëüí³ êë³òèíè, òðîôîáëàñò, äèôåðåíö³þâàííÿ.
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Â. À. Øàáëèé, Ì. Ä. Êó÷ìà, Â. Ì. Êèðèê, À. Í. Ñâèòèíà,
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Ðåçþìå
Öåëü. Èññëåäîâàòü ýêñïðåññèþ ìàðêåðîâ òðîôîáëàñòà â ìóëüòè-
ïîòåíòíûõ ñòðîìàëüíûõ êëåòêàõ â òêàíè ïëàöåíòû è â óñëîâèÿõ
èõ êóëüòèâèðîâàíèÿ. Ìåòîäû. Ìóëüòèïîòåíòíûå ìåçåíõèìàëü-
íûå ñòðîìàëüíûå êëåòêè (ÌÌÑÊ) ïîëó÷àëè êóëüòèâèðîâàíèåì
àäãåçèâíîé ôðàêöèè ñóñïåíçèè êëåòîê òêàíè ïëàöåíòû, èììóíî-
ôåíîòèïèðîâàíèå êëåòîê ïðîâîäèëè ñ ïîìîùüþ ïðîòî÷íîé öèòî-
ôëóîðîìåòðèè è èììóíîöèòîõèìèè. Ðåçóëüòàòû. Ïîêàçàíî, ÷òî
ÌÌÑÊ ïëàöåíòû ýêñïðåññèðóþò ìàðêåðû òðîôîáëàñòà: õîðèî-
íè÷åñêèé ãîíàäîòðîïèí, öèòîêåðàòèíû ÀÅ1/ÀÅ3, ðåöåïòîð ýïè-
äåðìàëüíîãî ôàêòîðà ðîñòà HER2. Â òêàíè ïëàöåíòû ïðèñóò-
ñòâóþò ïîõîæèå ïî èììóíîôåíîòèïó íà ÌÌÑÊ ïîïóëÿöèè CD
90
+
CD73
+
CD45
–
CD34
–
CD14
–
-êëåòîê è CD90
–
CD73
+
CD45
–
CD34
–
CD14
–
-êëåòîê. Âûâîäû. Ïëàöåíòàðíûå ÌÌÑÊ îäíîâðåìåííî ýêñ-
ïðåññèðóþò ìåçåíõèìàëüíûå è òðîôîáëàñòíûå ìàðêåðû.
Êëþ÷åâûå ñëîâà: ïëàöåíòà, õîðèîí, ìóëüòèïîòåíòíûå ìåçåí-
õèìàëüíûå ñòðîìàëüíûå êëåòêè, òðîôîáëàñò, äèôôåðåíöèðîâêà.
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